• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microb Genom . Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome

tetano

Editor, Senior Moderator
Microb Genom


. 2023 Jun;9(6).
doi: 10.1099/mgen.0.001027. Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNet

Emily A Smith[SUP] 1 [/SUP], Kevin G Libuit[SUP] 1 [/SUP], Curtis J Kapsak[SUP] 1 [/SUP], Michelle R Scribner[SUP] 1 [/SUP], Sage M Wright[SUP] 1 [/SUP], John Bell[SUP] 2 [/SUP], Christina Morales[SUP] 2 [/SUP], Megan Crumpler[SUP] 3 [/SUP], Sharon Messenger[SUP] 2 [/SUP], Jill K Hacker[SUP] 2 [/SUP], Katya Ledin[SUP] 2 [/SUP], Carol Glaser[SUP] 2 [/SUP], Kathleen Jacobson[SUP] 2 [/SUP], Joel R Sevinsky[SUP] 1 [/SUP], Debra A Wadford[SUP] 2 [/SUP]



Affiliations
Abstract

The capacity for pathogen genomics in public health expanded rapidly during the coronavirus disease 2019 (COVID-19) pandemic, but many public health laboratories did not have the infrastructure in place to handle the vast amount of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequence data generated. The California Department of Public Health, in partnership with Theiagen Genomics, was an early adopter of cloud-based resources for bioinformatics and genomic epidemiology, resulting in the creation of a SARS-CoV-2 genomic surveillance system that combined the efforts of more than 40 sequencing laboratories across government, academia and industry to form California COVIDNet, California's SARS-CoV-2 Whole-Genome Sequencing Initiative. Open-source bioinformatics workflows, ongoing training sessions for the public health workforce, and automated data transfer to visualization tools all contributed to the success of California COVIDNet. While challenges remain for public health genomic surveillance worldwide, California COVIDNet serves as a framework for a scaled and successful bioinformatics infrastructure that has expanded beyond SARS-CoV-2 to other pathogens of public health importance.

Keywords: California COVIDNet; SARS-CoV-2; bioinformatics; pathogen genomics; public health; whole-genome sequencing.

 
Back
Top Bottom